|
|
||||||||

* Department of Internal Medicine, State University of New York at Buffalo, Buffalo General Hospital/Kaleida Health System, Buffalo, New York 14203; and
Department of Molecular and Cellular Biology, Roswell Park Cancer Institute, Buffalo, New York 14263
To whom requests for reprints should be addressed at 1 The Department of Internal Medicine, State University of New York at Buffalo, Buffalo General Hospital/Kaleida Health System, 100 High Street, Buffalo, NY 14203. E-mail: jlambrus{at}netscape.net
Many attempts have been made to inhibit viral and neoplastic diseases by targeting the RNA system. The pathophysiologic significance of the microRNA system and the therapeutic potential of its manipulation are discussed. Studies of double-stranded RNA derivatives are reviewed. The therapeutic potential of one of these compounds, polyI:MPC, is emphasized. Studies of other related antiviral and antineoplastic agents are discussed, including 2'-deoxyoligocytidilates and telomerase inhibitors.
Key Words: AIDS double-stranded and single-stranded RNA HIV infection neoplastic diseases thiolated polyI:polyC (pI:MPC) 2'-deoxyoligocytidilates telomerase inhibitors viral diseases
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |